{"Q": 1, "answer": "no", "rationale": "The segment does not contain an intensifier or comparative adjective directly modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_12056", "batch_size": 260, "batch_pos": 57, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain high-potency verbs, potent metaphors, superlative negative nouns, or critical alert phrases.", "method": "llm_batch", "batch_id": "batch_2_1320", "batch_size": 260, "batch_pos": 33, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 3, "answer": "no", "rationale": "The segment states 'can confirm we are in discussions' on 'advancing our pandemic flu candidate', which are actions/discussions, not realised impact.", "method": "llm_batch", "batch_id": "batch_3_6056", "batch_size": 260, "batch_pos": 234, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 4, "answer": "no", "rationale": "No loaded rhetorical question is present in the segment.", "method": "llm_batch", "batch_id": "batch_4_9220", "batch_size": 260, "batch_pos": 217, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 5, "answer": "no", "rationale": "This segment reports factual information without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_17372", "batch_size": 260, "batch_pos": 215, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 6, "answer": "no", "rationale": "No minimiser + scale contrast found.", "method": "llm_batch", "batch_id": "batch_6_15604", "batch_size": 260, "batch_pos": 187, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 7, "answer": "no", "rationale": "The segment does not contain a bare negation or an explicit calming cue.", "method": "llm_batch", "batch_id": "batch_7_17208", "batch_size": 260, "batch_pos": 176, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
{"Q": 8, "answer": "yes", "rationale": "The segment confirms discussions on advancing a candidate ('confirm we are in discussions... on advancing our pandemic flu candidate') which is a capability/preparedness statement without active reassurance.", "method": "llm_batch", "batch_id": "batch_8_14516", "batch_size": 260, "batch_pos": 26, "statement_text": "Moderna can confirm we are in discussions with the U.S. government on advancing our pandemic flu candidate, mRNA-1018, the company said in a statement to MarketWatch.", "article_id": 1648}
